Aldeyra Therapeutics Inc
ALDX
Market Cap$257.55M
Close$
$0.66
84.7% downside
Current Fair Value
84.7% downsideOvervalued by 84.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $257.55 Million |
|---|---|
| Enterprise Value | $-43,536,102,448,920.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.94 |
| Beta | 0.68 |
| Outstanding Shares | 59,887,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.46 |
|---|---|
| PEG | -19.53 |
| Price to Sales | - |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | -178042835.73 |
| Enterprise Value to EBIT | 738785.85 |
| Enterprise Value to Net Income | 754540 |
| Total Debt to Enterprise | -0.16 |
| Debt to Equity | 0.11 |
Revenue Sources
No data
Insider Trades
ESG Score
No data